metoprolol has been researched along with Albuminuria in 23 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Albuminuria: The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the long-term effects of the angiotensin-converting enzyme (ACE)-inhibitor quinapril and the cardioselective beta-adrenergic blocking agent metoprolol on glycaemic control, with glycosylated haemoglobin (HbA1c) as the principal variable, in non-insulin-dependent diabetes mellitus (NIDDM) patients with hypertension." | 9.08 | Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group. ( Asplund, K; Bystedt, T; Dahlöf, B; Jern, S; Kjellström, T; Lithell, H; Ostman, J, 1998) |
| "Antihypertensive treatment with enalapril reduced proteinuria in patients with diabetic nephropathy more than an equally effective antihypertensive treatment with metoprolol." | 9.06 | Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. ( Aurell, M; Björck, S; Johnsen, SA; Mulec, H; Nyberg, G, 1990) |
| "To compare responses of blood pressure to the calcium antagonist verapamil and the beta blocker metoprolol in black compared with white diabetics with hypertension and to monitor urinary albumin excretion in relation to fall in blood pressure." | 9.06 | Treating hypertension in black compared with white non-insulin dependent diabetics: a double blind trial of verapamil and metoprolol. ( Anderson, NM; Cruickshank, JK; Jepson, E; Wadsworth, J; Young, SM, 1988) |
| "We compared the effects of the angiotensin-converting enzyme inhibitor enalapril and a conventional antihypertensive regimen (hydralazine and metoprolol) on kidney function, albuminuria, and glomerular ultrastructure in hypertensive diabetic and nondiabetic rats." | 7.68 | Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy. ( Allen, TJ; Clarke, BE; Cooper, ME; Doyle, AE; Jerums, G; O'Brien, RC; Papazoglou, D, 1990) |
| "Metoprolol treatment improved in vagal tone assessed by short-term spectral analysis." | 6.70 | Effects on heart rate variability of metoprolol supplementary to ongoing ACE-inhibitor treatment in Type I diabetic patients with abnormal albuminuria. ( Ebbehøj, E; Hansen, KW; Knudsen, ST; Mogensen, CE; Mølgaard, H; Poulsen, PL, 2002) |
| "8 years) with microalbuminuria 31 (19-160) microg/min were randomised to treatment with enalapril (group 1, n = 7) or metoprolol (group 2, n = 6)." | 5.09 | Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus. ( Bangstad, HJ; Dahlquist, G; Osterby, R; Persson, B; Rudberg, S, 1999) |
| "To compare the long-term effects of the angiotensin-converting enzyme (ACE)-inhibitor quinapril and the cardioselective beta-adrenergic blocking agent metoprolol on glycaemic control, with glycosylated haemoglobin (HbA1c) as the principal variable, in non-insulin-dependent diabetes mellitus (NIDDM) patients with hypertension." | 5.08 | Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group. ( Asplund, K; Bystedt, T; Dahlöf, B; Jern, S; Kjellström, T; Lithell, H; Ostman, J, 1998) |
| "The effects of long-term treatment with captopril and conventional therapy on albuminuria and metabolic parameters were compared in 74 hypertensive type II diabetics with normal serum creatinine." | 5.07 | Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis. ( Lacourcière, Y; Nadeau, A; Poirier, L; Tancrède, G, 1993) |
| "Antihypertensive treatment with enalapril reduced proteinuria in patients with diabetic nephropathy more than an equally effective antihypertensive treatment with metoprolol." | 5.06 | Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. ( Aurell, M; Björck, S; Johnsen, SA; Mulec, H; Nyberg, G, 1990) |
| "To compare responses of blood pressure to the calcium antagonist verapamil and the beta blocker metoprolol in black compared with white diabetics with hypertension and to monitor urinary albumin excretion in relation to fall in blood pressure." | 5.06 | Treating hypertension in black compared with white non-insulin dependent diabetics: a double blind trial of verapamil and metoprolol. ( Anderson, NM; Cruickshank, JK; Jepson, E; Wadsworth, J; Young, SM, 1988) |
| "We compared the effects of the angiotensin-converting enzyme inhibitor enalapril and a conventional antihypertensive regimen (hydralazine and metoprolol) on kidney function, albuminuria, and glomerular ultrastructure in hypertensive diabetic and nondiabetic rats." | 3.68 | Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy. ( Allen, TJ; Clarke, BE; Cooper, ME; Doyle, AE; Jerums, G; O'Brien, RC; Papazoglou, D, 1990) |
| "Metoprolol treatment improved in vagal tone assessed by short-term spectral analysis." | 2.70 | Effects on heart rate variability of metoprolol supplementary to ongoing ACE-inhibitor treatment in Type I diabetic patients with abnormal albuminuria. ( Ebbehøj, E; Hansen, KW; Knudsen, ST; Mogensen, CE; Mølgaard, H; Poulsen, PL, 2002) |
| "Five patients with incipient diabetic nephropathy participated in a long-term study." | 2.66 | Acute and long-term effect of antihypertensive treatment on exercise-induced albuminuria in incipient diabetic nephropathy. ( Christensen, CK; Mogensen, CE, 1986) |
| "Participants with hypertension and type 2 diabetes were randomized to either metoprolol tartrate (n=737) or carvedilol (n=498) in blinded fashion after a washout period of all antihypertensive agents except for angiotensin-converting enzyme inhibitors or angiotensin receptor blockers." | 1.33 | Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes. ( Anderson, KM; Bakris, GL; Bell, DS; Fonseca, V; Katholi, RE; Lukas, MA; McGill, JB; Messerli, F; Phillips, RA; Raskin, P; Waterhouse, B; Wright, JT, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (34.78) | 18.7374 |
| 1990's | 10 (43.48) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebbehøj, E | 2 |
| Poulsen, PL | 2 |
| Hansen, KW | 3 |
| Knudsen, ST | 1 |
| Mølgaard, H | 2 |
| Mogensen, CE | 4 |
| Arildsen, H | 1 |
| Bakris, GL | 1 |
| Fonseca, V | 1 |
| Katholi, RE | 1 |
| McGill, JB | 1 |
| Messerli, F | 1 |
| Phillips, RA | 1 |
| Raskin, P | 1 |
| Wright, JT | 1 |
| Waterhouse, B | 1 |
| Lukas, MA | 1 |
| Anderson, KM | 1 |
| Bell, DS | 1 |
| Joles, JA | 1 |
| Nicaise, E | 1 |
| Sanders, M | 1 |
| Schot, A | 1 |
| Rossing, P | 1 |
| Hommel, E | 2 |
| Smidt, UM | 1 |
| Parving, HH | 2 |
| Rudberg, S | 4 |
| Sätterström, G | 1 |
| Dahlqvist, R | 1 |
| Dahlquist, G | 2 |
| Ljungman, S | 1 |
| Wikstrand, J | 1 |
| Hartford, M | 1 |
| Aurell, M | 2 |
| Lindstedt, G | 1 |
| Berglund, G | 1 |
| Lacourcière, Y | 1 |
| Nadeau, A | 1 |
| Poirier, L | 1 |
| Tancrède, G | 1 |
| Ostman, J | 1 |
| Asplund, K | 1 |
| Bystedt, T | 1 |
| Dahlöf, B | 1 |
| Jern, S | 1 |
| Kjellström, T | 1 |
| Lithell, H | 1 |
| Osterby, R | 3 |
| Bangstad, HJ | 3 |
| Persson, B | 1 |
| Nyberg, G | 2 |
| Gulmann, C | 1 |
| Teschner, M | 1 |
| Schaefer, RM | 1 |
| Bahner, U | 1 |
| Heidland, A | 1 |
| Pedersen, MM | 1 |
| Christensen, CK | 3 |
| Christiansen, JS | 1 |
| Cooper, ME | 1 |
| Allen, TJ | 1 |
| O'Brien, RC | 1 |
| Papazoglou, D | 1 |
| Clarke, BE | 1 |
| Jerums, G | 1 |
| Doyle, AE | 1 |
| Björck, S | 1 |
| Mulec, H | 1 |
| Johnsen, SA | 1 |
| Cruickshank, JK | 2 |
| Anderson, NM | 2 |
| Wadsworth, J | 2 |
| Young, SM | 2 |
| Jepson, E | 2 |
| Baba, T | 1 |
| Sawicki, PT | 1 |
| Mathiesen, ER | 1 |
| Friedman, PJ | 1 |
| Dunn, PJ | 1 |
| Jury, DR | 1 |
| Krusell, LR | 1 |
1 review available for metoprolol and Albuminuria
| Article | Year |
|---|---|
[Nephropathy in type 1 diabetes mellitus. Current experimental and clinical aspects].
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Dia | 1992 |
12 trials available for metoprolol and Albuminuria
| Article | Year |
|---|---|
Effects on heart rate variability of metoprolol supplementary to ongoing ACE-inhibitor treatment in Type I diabetic patients with abnormal albuminuria.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitor | 2002 |
Effects of metoprolol on QT interval and QT dispersion in Type 1 diabetic patients with abnormal albuminuria.
Topics: Administration, Oral; Adult; Albuminuria; Chronic Disease; Cross-Over Studies; Denmark; Diabetes Mel | 2004 |
Reduction in albuminuria predicts diminished progression in diabetic nephropathy.
Topics: Adult; Albuminuria; Antihypertensive Agents; Cohort Studies; Diabetic Nephropathies; Female; Forecas | 1994 |
Indomethacin but not metoprolol reduces exercise-induced albumin excretion rate in type 1 diabetic patients with microalbuminuria.
Topics: Adult; Albuminuria; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies | 1993 |
Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.
Topics: Aged; Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Doub | 1993 |
Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.
Topics: Adrenergic beta-Antagonists; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypert | 1998 |
Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitor | 1999 |
Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.
Topics: Adult; Albuminuria; Blood Pressure; Diabetic Nephropathies; Enalapril; Humans; Metoprolol; Middle Ag | 1990 |
Treating hypertensive diabetics: a comparison of verapamil and metoprolol in black and white patients.
Topics: Albuminuria; Black People; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Complications; Diabe | 1987 |
Acute and long-term effect of antihypertensive treatment on exercise induced microalbuminuria in essential hypertension.
Topics: Adult; Albuminuria; Atenolol; beta 2-Microglobulin; Blood Pressure; Clinical Trials as Topic; Double | 1987 |
Treating hypertension in black compared with white non-insulin dependent diabetics: a double blind trial of verapamil and metoprolol.
Topics: Aged; Albuminuria; Black or African American; Clinical Trials as Topic; Diabetes Mellitus, Type 2; D | 1988 |
Acute and long-term effect of antihypertensive treatment on exercise-induced albuminuria in incipient diabetic nephropathy.
Topics: Adult; Albuminuria; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus; Diabetic Nephropath | 1986 |
10 other studies available for metoprolol and Albuminuria
| Article | Year |
|---|---|
Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Albuminuria; Blood Pressure; Carbazoles | 2005 |
Effects of NaHCO3, alpha-, and beta-adrenergic blockade on albuminuria after swimming in splenectomized dogs.
Topics: Acidosis; Albuminuria; Animals; Bicarbonates; Blood; Dogs; Hydrogen-Ion Concentration; Metoprolol; M | 1984 |
Effects of long-term antihypertensive treatment and aging on renal function and albumin excretion in primary hypertension.
Topics: Aging; Albuminuria; Case-Control Studies; Drug Therapy, Combination; Follow-Up Studies; Glomerular F | 1993 |
On glomerular structural alterations in type-1 diabetes. Companions of early diabetic glomerulopathy.
Topics: Adult; Albuminuria; Capillaries; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enalapril; Extra | 2001 |
The juxtaglomerular apparatus in young type-1 diabetic patients with microalbuminuria. Effect of antihypertensive treatment.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitor | 2001 |
ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
Topics: Adult; Albuminuria; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, | 1991 |
Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy.
Topics: Administration, Oral; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Melli | 1990 |
Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat: are these effects specific for enalapril?
Topics: Albuminuria; Animals; Basement Membrane; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic N | 1989 |
Converting enzyme-inhibition in diabetic nephropathy.
Topics: Albuminuria; Blood Pressure; Captopril; Diabetic Nephropathies; Drug Therapy, Combination; Furosemid | 1989 |
Metoprolol and albumin excretion in diabetes.
Topics: Adult; Albuminuria; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Male; Metoprolol; Mid | 1986 |